Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
about
Fluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityEffect of recombinant human erythropoietin on anticancer drug-induced anaemiaToxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.Cisplatin-associated anemia: an erythropoietin deficiency syndrome.Tissue organ distribution and behavioral effects of platinum following acute and repeated exposure of the mouse to platinum sulfateCisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot studyLack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.Effects of cisplatin on different haemopoietic progenitor cells in miceThe effect of combined treatment with a platinum complex and ionizing radiation on chinese hamster ovary cells in vitroThe Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin.Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers.Ototoxicity of cisplatin in gynaecological cancer patients.RENAL COMPLICATIONS OF CYTOTOXIC THERAPY
P2860
Q24236119-0FCF1540-A812-4639-8F20-F23355B92A8CQ24242032-8216CDFF-7E16-4067-A8F3-55C39593AED0Q28331270-BC030EBC-E12B-40D7-BFB1-602BE76D3FFBQ33382359-38671CCA-73AA-4CF5-9623-3ACCC7099FA9Q34208295-A3287BA6-86B3-4505-B55E-84760CBD4B3FQ35035408-881736E4-9F46-458E-9128-0003B7F63ED9Q35975860-D3D67CEA-E81B-42E3-80A9-0B5CB13B6485Q35976887-5C567CC2-D5C7-497A-9689-01358A2C587FQ36047032-D9EC3D96-3746-4D73-B98A-9B79FF4FFA83Q36068602-B76EB702-887D-49C1-AD68-DB77EF69EAAAQ36688160-E9DAB87E-1490-4D50-96CA-11742AFF3F8DQ48285361-6B13049C-C635-403A-9947-46C63226D11AQ50568908-D8909353-E888-43F4-BDEE-F8D5241E8CBEQ58887666-8936178E-D494-45AE-9091-4698A57FA47C
P2860
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
description
1972 nî lūn-bûn
@nan
1972 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@ast
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@en
type
label
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@ast
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@en
prefLabel
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@ast
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@en
P2093
P1433
P1476
Preliminary clinical experienc ...... tinum (II) (NSC 119875, CACP).
@en
P2093
P304
P356
10.1002/1097-0142(197212)30:6<1451::AID-CNCR2820300606>3.0.CO;2-Q
P407
P577
1972-12-01T00:00:00Z